InSoma Bio specializes in developing innovative biomaterials for reconstructive plastic surgery, leveraging bio-inspired technologies to enhance surgical procedures. Their flagship product, Fractomer, is a protein-based biomatrix that behaves like a liquid at room temperature but rapidly transforms into a solid, porous scaffold at body temperature. This unique thermal switch allows for the easy handling and injection of the material, which can be combined with a patient’s own fat harvested through liposuction. The Fractomer scaffold not only stabilizes the injected fat but also mimics natural tissue structures, promoting effective integration and nutrient flow, thereby improving the outcomes of procedures like breast and facial reconstruction.

The technology behind Fractomer is rooted in genetic engineering, allowing for the design of materials that replicate the proteins found in the human body. This approach provides several advantages over traditional reconstructive materials, which can be costly or prone to side effects. By creating a bio-compatible, mechanically supportive, and easily vascularized scaffold, InSoma Bio aims to merge the benefits of synthetic polymers with the natural integration properties of native proteins. This innovative solution addresses the limitations of existing materials, offering a more effective and patient-friendly option for soft-tissue reconstruction.

United States

InSoma Bio is a company that borrows nature's own designs to develop unique products for reconstructive plastic surgery. Their product enables surgeons to use a person's own tissues to enhance the stability of autologous fat grafts and solve problems in tissue engineering and regenerative medicine.

inSoma Bio

Company Details